Entyvio receives FDA approval for the treatment of ulcerative colitis and Crohn’s disease

The U.S. Food and Drug Administration Tuesday approved Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn’s disease.Entyvio More...